Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Serina Therapeutics Inc SER

Healthcare Biotechnology
Serina Therapeutics, Inc., formerly AgeX Therapeutics, Inc., is a clinical-stage biotechnology company. The Company is engaged in developing a pipeline of wholly owned drug product candidates to treat neurological diseases and pain. Its POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the... see more

Recent & Breaking News (NYSEAM:SER)

    Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients

    GlobeNewswire 1 day ago

    Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights

    GlobeNewswire November 12, 2024

    Serina Therapeutics Makes Grants to New Employees Under Inducement Plan

    GlobeNewswire November 11, 2024

    Serina Therapeutics to Present at the 14th Annual Injectables Summit

    GlobeNewswire October 2, 2024

    Serina Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

    GlobeNewswire September 4, 2024

    Serina Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights

    GlobeNewswire August 9, 2024

    Serina Therapeutics to Present Novel Data on POZ-Lipid Technology Potentially Enhancing Safety and Efficacy of mRNA LNP Formulations at the 4th mRNA-Based Therapeutics Summit

    GlobeNewswire July 29, 2024

    Serina Therapeutics Appoints Srini Tenjarla, Ph.D. as Senior Vice President of CMC and Formulation

    GlobeNewswire July 18, 2024

    Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights

    GlobeNewswire May 14, 2024

    Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman

    GlobeNewswire April 17, 2024